Assessment of Complication Risk Factors in a French National Cohort of Asplenic Patients

ConditionAsplenia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPoitiers University Hospital

About this trial

Spleen could have been surgically removed for trauma, cancer, auto-immune disease, or to perform a diagnosis. Spleen could be non-functional due to radiotherapy or splenic artery embolism. These patients are at risks of infectious diseases due to encapsulated bacteria, cancer, and thromboembolism disease. The purpose of this study is to assess complications occurring in French patients without spleen and to implement new diagnostic tools for follow-up.

Eligibility criteria

Qualifiers

≥18 year-old

With asplenia due to splenectomy, splenic artery embolization or radiotherapy

Disqualifiers

Genetic asplenia including sick cell disease

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

6,000 Participants
are grouped into 1 trial group

Sponsors and collaborators

Poitiers University Hospital

Lead sponsor

Pr Pierre BUFFET Institut National de la Transfusion Sanguine

Collaborator

Dr Edouard TUAILLON Département Bactériologie-Virologie/INSERM U1058 CHU de Montpellier

Collaborator